Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is positioned for success due to their strong growth and strategic focus on expansion. With partnerships with major health plans and a potential for widespread adoption of their program, the company is expected to continue performing well and potentially exceed their raised guidance and target model. Analysts view the stock positively and have raised their price target to $76.00 per share.

Bears say

Hinge Health is a tech platform that uses AI-powered motion tracking technology to help individuals treat and prevent joint and muscle pain. Despite its scale, technology, and relationships with major health plans, the company has experienced limited success due to difficulties in engaging end-users, high customer churn, and the challenging nature of accurately measuring ROI in healthcare. Additionally, while the company's recent financial performance has seen strong revenue growth and improved profitability, these positive trends may be unsustainable given the highly competitive and rapidly evolving healthcare market.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.